Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation

NCT01972035 is registered in ClinicalTrials.gov with University of Minnesota as lead sponsor.

NCT NCT01972035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01972035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ValGanciclovir Versus ValAcyclovir for Viral Prophylaxis in Kidney Transplantation
Lead sponsor
University of Minnesota
Phase
Phase 2
Overall status
Completed
Start date
August 1, 2014
Completion date
February 28, 2021
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cytomegalovirus infections, epstein-barr virus infections, transplantation infection